| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |